Macrophages contribute to the antitumor activity of the anti-CD30 antibody SGN-30
Open Access
- 15 December 2007
- journal article
- Published by American Society of Hematology in Blood
- Vol. 110 (13), 4370-4372
- https://doi.org/10.1182/blood-2007-06-097014
Abstract
Increased expression of CD30 is associated with a variety of hematologic malignancies, including Hodgkin disease (HD) and anaplastic large cell lymphoma (ALCL). The anti-CD30 monoclonal antibody SGN-30 induces direct antitumor activity by promoting growth arrest and DNA fragmentation of CD30+ tumor cells. In this study, we investigated the contributions of Fc-mediated effector cell functions to SGN-30 activity. We determined that antibody-dependent cellular phagocytosis, mediated by macrophages, to contribute significantly to antitumor activity in vitro. To delineate the identity of the host effector cells involved in mediating antitumor activity in vivo, we studied the effects of effector cell ablation in a disseminated model of HD (L540cy). Depletion of macrophages markedly reduced efficacy of SGN-30, demonstrating that macrophages contribute significantly to SGN-30 efficacy in this model. These findings may have implications for patient stratification or combination treatment strategies in clinical trials conducted with SGN-30 in HD and ALCL.Keywords
This publication has 16 references indexed in Scilit:
- Engineered anti-CD70 antibody with multiple effector functions exhibits in vitro and in vivo antitumor activitiesBlood, 2006
- Distinct Role of Macrophages in Different Tumor MicroenvironmentsCancer Research, 2006
- Signaling via the anti-CD30 mAb SGN-30 sensitizes Hodgkin's disease cells to conventional chemotherapeuticsLeukemia, 2005
- Importance of Cellular Microenvironment and Circulatory Dynamics in B Cell ImmunotherapyPublished by The American Association of Immunologists ,2005
- The Innate Mononuclear Phagocyte Network Depletes B Lymphocytes through Fc Receptor–dependent Mechanisms during Anti-CD20 Antibody ImmunotherapyThe Journal of Experimental Medicine, 2004
- Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa geneBlood, 2002
- CD30 in Normal and Neoplastic CellsClinical Immunology, 1999
- Elimination, blocking, and activation of macrophages: three of a kind?Journal of Leukocyte Biology, 1997
- Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applicationsJournal of Immunological Methods, 1994
- Atypical Cells in Lymphomatoid Papulosis Express the Hodgkin Cell-Associated Antigen Ki-1Journal of Investigative Dermatology, 1986